Reporting to the Chief Commercialization Officer, this leader will build and lead an integrated value, access, and pricing function spanning U.S. payer strategy, reimbursement strategy, HEOR and evidence generation, access policy, international access, trade and channel strategy, patient services, and payer access to genetic testing for genetic cardiomyopathies. Lead Rocket's HEOR, evidence generation, and value demonstration strategy across the portfolio to support payer decision-making, HTA and reimbursement requirements, genetic testing access, clinical development planning, evidence packages, publications, payer communications, and regulatory and post-approval evidence strategy.